MF64

ICD-11 MMS 2026-01

Abnormal immunological findings in specimens from female genital organs

Index terms

  • Abnormal immunological findings in specimens from female genital organs

Exclusions from above levels

  • 2E67 – Carcinoma in situ of other or unspecified genital organs
  • GA13.1 – Low grade squamous intraepithelial lesion of vulva
  • GA15.7 – Low grade squamous intraepithelial lesion of cervix uteri
Show allHide
  • 19 – Certain conditions originating in the perinatal period
  • JA66 – Clinical findings on antenatal screening of mother

Sibling codes

  • MF60 – Abnormal level of enzymes in specimens from female genital organs
  • MF61 – Abnormal level of hormones in specimens from female genital organs
  • MF62 – Abnormal level of drugs, medicaments or biological substances in specimens from female genital organs
  • MF63 – Abnormal level of substances chiefly nonmedicinal as to source in specimens from female genital organs
  • MF65 – Abnormal microbiological findings in specimens from female genital organs
  • MF66 – Abnormal cytological findings in specimens from female genital organs
  • MF67 – Abnormal histological findings in specimens from female genital organs
  • MF68 – Abnormal chromosomal findings in specimens from female genital organs
  • MF6Y – Other specified clinical findings in specimens from female genital organs
  • MF6Z – Clinical findings in specimens from female genital organs, unspecified

Foundation entity

Abnormal immunological findings in specimens from female genital organs – http://id.who.int/icd/entity/1571355169

Allowed postcoordination axes

Part of: 21: Symptoms, signs or clinical findings, not elsewhere classified